Acute Myelogenous Leukemia (AML or ANLL)

specific

A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).

30

Centers

30

Active Trials

—

Cancer Funding

Top Centers for Acute Myelogenous Leukemia (AML or ANLL)(30)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
51.7
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
Active Research Program
51.7
3
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
Active Research Program
51.7
4
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
Active Research Program
51.7
5
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
51.7
6
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
51.7
7
Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN
NCI Comprehensive
Active Research Program
51.7
8
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
51.7
9
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
51.7
10
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
51.7
11
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
51.7
12
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
51.7
13
Medical College of Wisconsin Cancer CenterMilwaukee, WI
Active Research Program
51.7
14
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
51.7
15
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
51.7
16
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
51.7
17
University of Illinois Cancer CenterChicago, IL
Active Research Program
51.7
18
University of Hawai‘i Cancer CenterHonolulu, HI
NCI Clinical
Active Research Program
51.7
19
Boston University Cancer CenterBoston, MA
Active Research Program
51.7
20
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
Active Research Program
51.7
21
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
51.7
22
Cancer Center at IllinoisUrbana, IL
Active Research Program
51.7
23
Stony Brook Cancer CenterStony Brook, NY
Active Research Program
51.7
24
Penn State Cancer InstituteHershey, PA
Active Research Program
51.7
25
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
51.7
26
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
51.7
27
Georgia Cancer Center, Augusta UniversityAugusta, GA
Active Research Program
51.7
28
Loma Linda University Cancer CenterLoma Linda, CA
Active Research Program
51.7
29
Louisiana Cancer Research CenterNew Orleans, LA
Active Research Program
51.7
30
Tampa General Hospital Cancer InstituteTampa, FL
Active Research Program
51.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →